about
Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptorsN-Aryl Isoleucine Derivatives as Angiotensin II AT2 Receptor Ligands.Hypotensive Response to Angiotensin II Type 2 Receptor Stimulation in the Rostral Ventrolateral Medulla Requires Functional GABA-A Receptors.Nonclassical renin-angiotensin system and renal function.Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure.Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial AT₂R and cytoskeletal dysregulation.G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II.Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats.A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer CellsNovel roles of nuclear angiotensin receptors and signaling mechanisms.Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Enhanced Natriuresis and Diuresis in Wistar Rats Caused by the Costimulation of Renal Dopamine D3 and Angiotensin II Type 2 Receptors.Suppression of FoxO6 by lipopolysaccharide in aged rat liver.The renin-angiotensin system in 2011: new avenues for translational research.Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.Angiotensin-converting enzyme-induced activation of local angiotensin signaling is required for ascending aortic aneurysms in fibulin-4-deficient mice.AT(2) receptor and tissue injury: therapeutic implications.AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats.Activation of angiotensin type 2 receptors partially ameliorates streptozotocin-induced diabetes in male rats by islet protection.Angiotensin Type-2 (AT-2)-Receptor activation reduces renal fibrosis in cyclosporine nephropathy: Evidence for blood-pressure independent effect.Emerging drugs which target the renin-angiotensin-aldosterone system.The renin-angiotensin system, bone marrow and progenitor cells.New therapeutic pathways in the RAS.Prevention of coronary artery disease: recent advances in the management of hypertension.Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1-dependent diseases and longevity.Glucagon increase after chronic AT1 blockade is more likely related to an indirect leptin-dependent than to a pancreatic α-cell-dependent mechanism.Activating types 1 and 2 angiotensin II receptors modulate the hypertrophic differentiation of chondrocytes.Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats.Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice.Relationship between pre-stroke cardiovascular medication use and stroke severity.Angiotensin Receptor Blockade Modulates NFκB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition.The effect of high glucose on the inhibitory action of C21, a selective AT2R agonist, of LPS-stimulated tissue factor expression in human mononuclear cells.Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells.Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats.Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice.AT2 Receptor-Interacting Proteins ATIPs in the Brain.Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.
P2860
Q27023787-6524D2EA-A8ED-4C7E-8DE3-E370B7390582Q31160630-69D767CC-5828-4838-B425-BB84369F9510Q33809582-8831CF86-7DEC-4D56-84C4-AEEDA94C805EQ34293723-E728B3F6-24BA-4824-8F63-CA693D647677Q34500044-D0C5BFFF-4314-4C15-BB56-A3D0310F2EF1Q34940868-376E696B-F25D-4481-88C1-2512F2A71857Q35089791-4E75D587-5C17-411E-BE01-8E42F232F9F4Q35218190-62E0BA92-CAD1-4CC5-B0E8-223BA9ED35DAQ35484295-8BB1CC63-3350-4718-A49E-B3168EEA3522Q35601958-AAD21B60-F214-46D9-B75E-7B9896C574D3Q35609097-4B60B82B-BED2-4E69-B39D-2AAFDC4357EEQ35850244-2C7D8F82-A842-443C-A151-B8F92A1558ACQ35971305-0212191B-B70F-4409-811B-A0BEBAB10330Q36241932-C3BFEEAE-3853-439B-B3DF-05BF4FF16E1EQ36363450-7C667AAC-511B-414E-9899-D5D089CEF5DEQ36544036-65CAAB6C-F780-4FC1-9D63-F545BB110B78Q36979856-4DE443B8-59FA-426D-95C4-5127544BFAC6Q37147092-1D9036ED-99C7-4B9F-8944-607732804612Q37402767-5DABF02D-3075-4644-9199-7A91A47F1877Q37531017-D5C6D122-A6E3-45A0-BA7C-21AC585489D8Q37551661-1A3D742A-D734-4A6C-8A29-5AFF15E7F1BCQ37594080-A7E71C25-EE71-4C6E-933D-FB737BCD6E02Q37626862-DD8970A6-581A-4229-8A51-5BE1AD5DB89BQ37929786-BDE9A943-AA6C-4941-B439-0E1BD0A75C3EQ38006725-F50BE26B-26C0-41A2-BE76-370506DE9DBBQ38061106-E2B9ACA8-34E2-4846-995C-3F20BC4915FFQ38075808-0330EE6F-4C79-47FA-BA90-089FC9DA50ABQ38128777-C3F4C2FF-F603-47D6-8B31-BA1ACEE775FDQ38718531-AF00A8F7-5B79-46D1-8C18-D593715CB758Q39117200-1FCBDA20-A4EA-4DFC-B611-7890A2555967Q39485775-D0F830B0-7B13-4C76-BF50-DEA3822A5F7AQ39915071-5FD30A4C-4C55-4C02-A648-17FC79495BE8Q40169733-D30D2F97-03FD-4322-8079-B98EDE9FF701Q40212788-276731DC-EEBA-4902-B0E7-91314D9B9AAAQ41031121-9CFE7C82-A0CD-4D34-B70E-B6E28E125372Q41251046-D6BA1225-51B7-456A-9118-F35F889CE935Q41818299-4CC62E0A-8FA0-4BF0-B6CC-39759E344807Q41971058-0E2D70BD-F432-4C7B-91A1-A8504B2A5C54Q42154092-C7731E48-E9F1-4A14-B44D-AB1195F81ACDQ43880703-60A1FE3C-FE5C-4DA4-B90D-7C6FCC7E35BE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-peptide AT2-receptor agonists.
@en
Non-peptide AT2-receptor agonists.
@nl
type
label
Non-peptide AT2-receptor agonists.
@en
Non-peptide AT2-receptor agonists.
@nl
prefLabel
Non-peptide AT2-receptor agonists.
@en
Non-peptide AT2-receptor agonists.
@nl
P2093
P50
P1476
Non-peptide AT2-receptor agonists.
@en
P2093
Anders Hallberg
Charlotta Wallinder
Emma S Jones
Mats Larhed
Robert E Widdop
P304
P356
10.1016/J.COPH.2010.11.002
P577
2010-12-15T00:00:00Z